164 related articles for article (PubMed ID: 37209238)
1. Occult hepatitis C virus infection in hemodialysis patients who achieved a sustained virological response to directly acting antiviral drugs: is it a concern?
Naguib H; Abouelnaga SF; Elsayed MM
Int Urol Nephrol; 2024 Jan; 56(1):217-222. PubMed ID: 37209238
[TBL] [Abstract][Full Text] [Related]
2. Detection of Occult Hepatitis C Virus Infection in Egyptian Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents.
Mashaal AR; Abd El-Hameed M; El Ray AA; Mahmoud Diab T; Dawood RM; Shemis MA; Seyam M
Asian Pac J Cancer Prev; 2022 Sep; 23(9):2965-2971. PubMed ID: 36172658
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of occult hepatitis C virus infection in patients who achieved sustained virologic response to direct-acting antiviral agents.
Yousif MM; Elsadek Fakhr A; Morad EA; Kelani H; Hamed EF; Elsadek HM; Zahran MH; Fahmy Afify A; Ismail WA; Elagrody AI; Ibrahim NF; Amer FA; Zaki AM; Sadek AMEM; Shendi AM; Emad G; Farrag HA
Infez Med; 2018 Sep; 26(3):237-243. PubMed ID: 30246766
[TBL] [Abstract][Full Text] [Related]
4. Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality.
Wang Y; Rao H; Chi X; Li B; Liu H; Wu L; Zhang H; Liu S; Zhou G; Li N; Niu J; Wei L; Zhao J
EBioMedicine; 2019 Aug; 46():227-235. PubMed ID: 31345785
[TBL] [Abstract][Full Text] [Related]
5. Occult hepatitis C infection identified in injection drug users with direct antiviral agents therapy and spontaneous resolution of hepatitis C virus infection.
Silva E; Marques S; Leal B; Canhão B; Madaleno J; Simão A; Carvalho A
Virus Res; 2023 May; 329():199104. PubMed ID: 37003528
[TBL] [Abstract][Full Text] [Related]
6. Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents for Recurrent Infection After Liver Transplantation.
Elmasry S; Wadhwa S; Bang BR; Cook L; Chopra S; Kanel G; Kim B; Harper T; Feng Z; Jerome KR; Kahn JA; Saito T
Gastroenterology; 2017 Feb; 152(3):550-553.e8. PubMed ID: 27838287
[TBL] [Abstract][Full Text] [Related]
7. Occult hepatitis C virus infection among haemodialysis patients.
Ali NK; Mohamed RR; Saleh BE; Alkady MM; Farag ES
Arab J Gastroenterol; 2018 Sep; 19(3):101-105. PubMed ID: 30245116
[TBL] [Abstract][Full Text] [Related]
8. Occurrence and clinical characteristics of occult hepatitis C virus infection in hemodialysis units at Ismailia, Egypt.
Serwah MA; Omar SA; Khedr MS; Abdel-Hamid AES
Eur J Gastroenterol Hepatol; 2021 Jul; 33(7):1009-1014. PubMed ID: 33731578
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of occult hepatitis C virus among hemodialysis patients in Tanta university hospitals: a single-center study.
Abdelmoemen G; Khodeir SA; Abou-Saif S; Kobtan A; Abd-Elsalam S
Environ Sci Pollut Res Int; 2018 Feb; 25(6):5459-5464. PubMed ID: 29214477
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C viral RNA in blood mononuclear cells of patients treated with directly acting antivirals.
Kamhawy A; Ahmed Said ZN; Abdelhamid SE; El-Sayed M; Eletreby R; Garem HE; El Kassas M; Esmat G
Arab J Gastroenterol; 2021 Jun; 22(2):158-163. PubMed ID: 33820724
[TBL] [Abstract][Full Text] [Related]
11. No evidence of occult hepatitis C or E virus infections in liver-transplant patients with sustained virological response after therapy with direct acting agents.
Del Bello A; Abravanel F; Alric L; Lavayssiere L; Lhomme S; Bellière J; Izopet J; Kamar N
Transpl Infect Dis; 2019 Aug; 21(4):e13093. PubMed ID: 30972874
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.
Chen LW; Chien RN; Yen CL; Chang JJ; Liu CJ; Lin CL
J Gastroenterol Hepatol; 2010 Feb; 25(2):259-63. PubMed ID: 19817959
[TBL] [Abstract][Full Text] [Related]
13. Detection of hepatitis C virus (HCV) RNA in the peripheral blood mononuclear cells of HCV-infected patients following sustained virologic response.
Khattab MA; Zakaria Y; Sadek E; Abd El Fatah AS; Fouad M; Khattab M; Moness HM; Adel NM; Ahmed E
Clin Exp Med; 2023 Feb; 23(1):131-140. PubMed ID: 35066710
[TBL] [Abstract][Full Text] [Related]
14. Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
Galán RJ; Cidoncha EC; Martin MF; Rodriguez CC; Almeida CV; Verdugo RM
J Manag Care Pharm; 2013; 19(6):448-53. PubMed ID: 23806058
[TBL] [Abstract][Full Text] [Related]
15. Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.
Ferraro D; Bonura C; Giglio M; Di Stefano R; Almasio PL; Di Marco V; Craxì A; Cacciola I; Squadrito G; Raimondo G
J Biol Regul Homeost Agents; 2003; 17(2):172-5. PubMed ID: 14518718
[TBL] [Abstract][Full Text] [Related]
16. Effect of anti-viral therapy for occult hepatitis C virus infection.
Pardo M; López-Alcorocho JM; Castillo I; Rodríguez-Iñigo E; Perez-Mota A; Carreño V
Aliment Pharmacol Ther; 2006 Apr; 23(8):1153-9. PubMed ID: 16611276
[TBL] [Abstract][Full Text] [Related]
17. Virological responses of pegylated interferon alpha-2a treatment in hemodialysis patients infected with hepatitis C.
Köse Ş; Senger SS; Ersan G; Çavdar G
Clin Exp Nephrol; 2013 Feb; 17(1):115-9. PubMed ID: 22814955
[TBL] [Abstract][Full Text] [Related]
18. Virus Elimination by Direct-Acting Antiviral Agents Impacts Glucose Homeostasis in Chronic Hepatitis C Patients.
Cheng CH; Chu CY; Chen HL; Lin IT; Wu CH; Lee YK; Bair MJ
Front Endocrinol (Lausanne); 2021; 12():799382. PubMed ID: 35095765
[TBL] [Abstract][Full Text] [Related]
19. Residual hepatitis C virus in peripheral blood mononuclear cell as a risk factor for hepatocellular carcinoma after achieving a sustained virological response: a dogma or fiction.
Hanafy AS; Seleem WM; Basha MAA; Marei AM
Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1275-1282. PubMed ID: 31149912
[TBL] [Abstract][Full Text] [Related]
20. Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience.
Alsaran K; Sabry A; Shaheen N
Int Urol Nephrol; 2011 Sep; 43(3):865-73. PubMed ID: 20490669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]